• Fujian Haixi Pharmaceuticals will hold a first extraordinary general meeting in Fuzhou, China on Aug. 4, 2026.
• Shareholders will vote on a proposed change of external auditor, with the board to set the remuneration.
• The meeting will also consider the proposed appointment of an executive director.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Fujian Haixi Pharmaceuticals Co. Ltd. published the original content used to generate this news brief via IIS, the regulatory disclosure system operated by the Hong Kong Stock Exchange (HKex) (Ref. ID: HKEX-EPS-20260715-12245397), on July 15, 2026, and is solely responsible for the information contained therein.